Company
Clinuvel Pharmaceuticals
ASX:CUV
Melanocortin photomedicine (tissue resilience).
At a glance
- Listing
- ASX:CUV
- Category
- ASX listed
- Headquarters
- Melbourne
- Market cap
- ~A$360M
Thesis
Why it is in this universe
- Category
- ASX listed
- Market
- Australia
- Recent inflection
- CUV105 Ph3 vitiligo enrolled; results H2 2026.
- Services
- None recorded
- People tracked
- 4
Market data
Listing and scale
| Metric | Detail |
|---|---|
| Exchange | ASX |
| Ticker | ASX:CUV |
| Secondary listing | None |
| Market cap | ~A$360M |
| Status | Listed and trading |
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.
Get in touch
Contact
- Address
- Melbourne
- Website
- No site on file
- Phone
- No public number published
- No public address published
Offering
What it sells today
No commercial services are recorded for this company yet.
People
Who variis tracks here (4)
variis does not publish portraits of named individuals without a licence to do so.
Recent inflection
What moved lately
CUV105 Ph3 vitiligo enrolled; results H2 2026.
Common questions
- Why does variis track Clinuvel Pharmaceuticals?
- Melanocortin photomedicine (tissue resilience).
- Is Clinuvel Pharmaceuticals publicly listed?
- Yes. It trades as ASX:ASX:CUV. Market capitalisation is in the ~A$360M range, recorded as a dated snapshot rather than a live quote.
- Where is Clinuvel Pharmaceuticals based?
- Melbourne
- Is Clinuvel Pharmaceuticals still trading?
- Clinuvel Pharmaceuticals is recorded as actively trading.
Keep reading
Related coverage from the newsroom.
Sources
What this profile is built on
No source is on file for this company yet. Treat everything above as unverified until one is.
Every entity profile on variis is sourced. Not investment advice.